Home » Topics » BioWorld

BioWorld
RSS

PHASE III DATA BOOSTS IMMUNOMEDICS

March 9, 1992

CELTRIX OFFERING BRINGS IN $23.6M

March 9, 1992

NEW FUNDS SEE BRIGHT SIDE TO PULLBACK

March 9, 1992

IMNR SAYS INVESTORS MISSED THE POINT

March 9, 1992

ASSAY LINKS HIV BURDEN TO STAGE OF DISEASE

March 6, 1992

INTERFERON WARRANT EXERCISE RAISES $3M

March 6, 1992

FDA APPROVES TWO LYME DISEASE TESTS

March 6, 1992

NEUREX FILES FOR IPO

March 6, 1992

PATCH DEVELOPER TO OFFER 3 MILLION SHARES

March 6, 1992

BIOLOGICS DIRECTOR HAS BIOTECH CREDENTIALS

March 6, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...